Teva Pharmaceutical Industries Ltd ADR (TEVA) is an Israeli global pharmaceutical company specialized in developing, producing and marketing affordable generics as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Established in Jerusalem in 1901, the company has a diversified commercial footprint with global operations in more than 60 countries.
Teva Pharmaceuticals' ADR, listed on the New York Stock Exchange, reflects the company's international reach and the confidence of international investors. ADRs (American Depositary Receipts) allow US investors to buy shares in foreign companies without the complications of dealing with foreign legal and financial regulations. The ADR works by instituting a US bank as a depositor for shares of the foreign company, which can then be traded on US exchanges.
Teva Pharmaceutical is the world's largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. The company utilizes its specialty and onco-generic capabilities to strive for a future where more people can access high-quality medicine.
Over the years, Teva has faced challenges such as allegations of price-fixing, hefty fines, and heavy competition in the generics market. Nonetheless, Teva maintains its commitment to lead the way in healthcare innovation and shape the future of treatment. Presently, their portfolio includes medicines for various diseases including disorders of the central nervous system, respiratory ailments, pain, and migraines.
Teva’s underlying mission is to improve health and wellness around the world. They are dedicated to making a difference in the lives of people every day by offering a patient-centric view that provides innovative and effective treatment options.
Teva's dedication to corporate responsibility is at the core of their business, with the company working to positively impact the environment, workforce, and the communities in which it operates. Through their environmental, social, and governance (ESG) strategy, they strive for responsible business practices and high standards of conduct.
Despite the challenges, Teva Pharmaceuticals continues to play a pivotal role in the global healthcare landscape. The company's research and development efforts, commitment to patient health, and global drive make it a key player in the international pharmaceutical industry.